long term glp 1 effects What are experts learning about the long-term of GLP-1 medications? As more people stay on these medications for longer periods of time, researchers are paying closer attention to potential side effects GLP-1R Agonists for Weight Loss

doi: 10.1055/s-2004-826162 [DOI] [PubMed] [Google Scholar] 10.Kim SJ, Nian C, Karunakaran S, Clee SM, Isales CM, McIntosh CH

Contact: (408) 662-6001 or Find us on Google Maps Map Location Ozempic San Jose Treat Now, Pay Later With Dr

Research has identified multiple pathways through which semaglutide impairs normal stomach function: Direct inhibition of gastric motility through vagus nerve modulation Disruption of gastric pacemaker cells that coordinate stomach contractions Impaired gastric accommodation in the fundus and body regions Antral hypomotility preventing proper food grinding and propulsion Dysregulation of pyloric sphincter relaxation blocking stomach emptying Alterations in small intestinal motility affecting the entire digestive process Clinical data reveals that up to 75% of patients with normal gastric emptying before receiving GLP-1 agonists developed delayed gastric emptying after treatment initiation, with some studies showing 30% experiencing severe delays qualifying as gastroparesis

Cagrilintide is a long-acting amylin analog that suppresses appetite through a pathway completely independent of GLP-1, while semaglutide provides the familiar GLP-1 receptor activation

However, our clinical experience warns of a need for intensive monitoring and deeper understanding, as their potent efficacy could also inadvertently lead to extreme dietary restriction and weight loss in some patients